Volume 144, Issue 2, Pages (February 2013)

Slides:



Advertisements
Similar presentations
Volume 141, Issue 5, Pages e1 (November 2011)
Advertisements

Volume 149, Issue 1, Pages (July 2015)
Volume 138, Issue 3, Pages (March 2010)
Covering the Cover Gastroenterology
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 138, Issue 2, Pages (February 2010)
Volume 133, Issue 2, Pages (August 2007)
Volume 140, Issue 2, Pages e2 (February 2011)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Multispectral Endoscopic Imaging of Colorectal Dysplasia In Vivo
Volume 134, Issue 7, Pages (June 2008)
Volume 137, Issue 1, Pages (July 2009)
Volume 151, Issue 2, Pages e12 (August 2016)
Volume 136, Issue 2, Pages e1 (February 2009)
Covering the Cover Gastroenterology
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 141, Issue 5, Pages e1 (November 2011)
Covering the Cover Gastroenterology
Volume 131, Issue 3, Pages (September 2006)
Volume 137, Issue 2, Pages (August 2009)
Volume 145, Issue 4, Pages e9 (October 2013)
Volume 144, Issue 5, Pages (May 2013)
Volume 149, Issue 1, Pages (July 2015)
Volume 136, Issue 2, Pages (February 2009)
Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery  Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.
Volume 133, Issue 6, Pages (December 2007)
Outcomes Among Living Liver Donors
Volume 134, Issue 1, Pages (January 2008)
Volume 143, Issue 6, Pages e1 (December 2012)
Volume 141, Issue 6, Pages (December 2011)
Volume 139, Issue 6, Pages (December 2010)
Molecular Imaging in Gastrointestinal Endoscopy
Novel Developments in Endoscopic Mucosal Imaging
Tissue-Engineered Cell Sheets for Stricture Prevention: A New Connection Between Endoscopy and Regenerative Medicine  Joshua D. Penfield, Emmanuel C.
Volume 144, Issue 5, Pages e1 (May 2013)
Volume 141, Issue 2, Pages (August 2011)
Volume 139, Issue 1, Pages (July 2010)
Volume 136, Issue 2, Pages (February 2009)
Volume 153, Issue 3, Pages e16-e17 (September 2017)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 19, Issue 4, Pages (April 2011)
Volume 138, Issue 5, Pages e3 (May 2010)
Volume 133, Issue 3, Pages (September 2007)
Volume 141, Issue 4, Pages e2 (October 2011)
Notch Activation as a Driver of Osteogenic Sarcoma
Volume 132, Issue 4, Pages (April 2007)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 139, Issue 2, Pages e6 (August 2010)
Volume 141, Issue 6, Pages e5 (December 2011)
Colon Cancer: An Update and Future Directions
Volume 140, Issue 3, Pages (March 2011)
Volume 138, Issue 2, Pages (February 2010)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 136, Issue 2, Pages e3 (February 2009)
Volume 139, Issue 3, Pages e6 (September 2010)
Covering the Cover Gastroenterology
Volume 139, Issue 6, Pages (December 2010)
Volume 145, Issue 4, Pages e3 (October 2013)
Volume 131, Issue 6, Pages (December 2006)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Volume 133, Issue 2, Pages (August 2007)
Volume 149, Issue 6, Pages (November 2015)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance  Valeria R. Fantin, Julie St-Pierre,
Molecular Imaging in Gastrointestinal Disease
This month in Gastroenterology
EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis  Szu-Wei Lee, Yijuan Zhang, Michael Jung, Nathalia Cruz, Basheer.
Volume 23, Issue 3, Pages (March 2015)
Volume 149, Issue 1, Pages (July 2015)
Volume 28, Issue 8, Pages e4 (August 2019)
Volume 146, Issue 4, Pages (April 2014)
Presentation transcript:

Volume 144, Issue 2, Pages 294-297 (February 2013) Optical Imaging of Periostin Enables Early Endoscopic Detection and Characterization of Esophageal Cancer in Mice  Gabrielle S. Wong, Peiman Habibollahi, Pedram Heidari, Ju–Seog Lee, Andres J. Klein–Szanto, Todd J. Waldron, Phyllis Gimotty, Hiroshi Nakagawa, Philip R. Taylor, Timothy C. Wang, Umar Mahmood, Anil K. Rustgi  Gastroenterology  Volume 144, Issue 2, Pages 294-297 (February 2013) DOI: 10.1053/j.gastro.2012.10.030 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Periostin is up-regulated in invasive human ESCC. (A) Schematic of prediction models constructed for evaluation of predicted outcomes based on gene expression signatures. (B) Kaplan–Meier plots of the overall survival (OS) of the 2 predicted groups of patients. The differences between groups were significant, as indicated by the log-rank test. (C) Comparison of relative periostin (POSTN) expression in gene expression dataset comparing invading vs noninvading EPC2-hTERT-EGFR-p53R175H cells grown in organotypic culture (OTC) to periostin expression in the gene expression dataset of matched ESCC tumors in the Shanxi cohort. Error bars represent ± standard error of the mean. *P < .05. (D) Immunoblot of POSTN (95 kilodaltons) expression in the panel of ESCC cell lines. β-actin was used as a loading control. (E) Fluorescent images of the periostin optical probe injected into nude mice bearing tumor xenografts of TE-11 and TT (white arrows). TT tumor xenografts were used as a negative control. The sternum is indicated by black arrowheads and the bladder is indicated by black arrows. (F) Quantification of fluorescent signal from the periostin optical probe detected from TE-11 and TT tumor xenografts (n = 5 from each group). Bar graphs represent target-to-background ratios ± standard error of the mean. *P < .05. Note that a background target-to-background ratio of 1 implies no increased probe uptake in tumor relative to background tissue. Gastroenterology 2013 144, 294-297DOI: (10.1053/j.gastro.2012.10.030) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Periostin expression is detected with increasing ESCC progression in the genetic mouse model of ESCC. (A) Immunoblot of periostin expression in mouse sera from 3 cohorts of mice at different stages of disease: control L2-cre; p120ctnLoxP/+, L2-cre; p120ctnLoxP/LoxP with mild dysplasia and L2-cre; p120ctnLoxP/LoxP with severe dysplasia (n = 6 mice from each group). Ponceau S staining of immunoblot was performed as loading control. (B) Enzyme-linked immunosorbent assay of periostin levels present in mouse sera from the earlier-described 3 cohorts of mice (n = 6 mice from each cohort). Error bars represent ± standard error of the mean. *P < .05. (C) Representative WL, NIR, and overlay images from upper-gastrointestinal endoscopies in mice from the earlier-described 3 cohorts. Color map represents the range of fluorescent signal intensities (200–1100) in images. (D) Quantification of the fluorescent signal from the periostin optical probe detected from upper-gastrointestinal endoscopies in mice from the earlier-described 3 cohorts (n = 3 from each cohort). Bar graphs represent target-to-background ratio ± standard error of the mean. *P < .05. (E) Histopathologic analysis of representative esophagi isolated from mice from the earlier-described 3 cohorts in top panels to bottom panels. Scale bars: 100 μmol/L. Gastroenterology 2013 144, 294-297DOI: (10.1053/j.gastro.2012.10.030) Copyright © 2013 AGA Institute Terms and Conditions